NVNO enVVeno Medical Corp
Healthcare · Market cap: $4.2M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $13.4K | $0 |
| 2022-Q3 | $47.6K | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $51.8K |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $330.9K | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $4.1K |
| 2025-Q4 | $0 | $1.8K |
| 2026-Q1 | $0 | $1.6K |
| 2026-Q2 | $0 | $1.4K |
| 2026-Q3 | $0 | $123 |
| 2026-Q4 | $0 | $0 |
Bought$422.4K10 buy days
Sold$60.8K6 sell days
Net insider flow+$361.6Knet buying · 5 years
Latest trade2026-09-11Duhay Francis
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-09-11 | Sell | Duhay Francis | Director | 11 | $11.21 | $123 | 1 |
| 2026-06-11 | Sell | Duhay Francis | Director | 140 | $10.31 | $1.4K | 1 |
| 2026-03-12 | Sell | Duhay Francis | Director | 140 | $11.52 | $1.6K | 1 |
| 2025-12-11 | Sell | Duhay Francis | Director | 4,900 | $0.36 | $1.8K | 1 |
| 2025-09-15 | Sell | Duhay Francis | Director | 4,900 | $0.83 | $4.1K | 1 |
| 2024-12-31 | Buy | Duhay Francis | Director | 81,433 | $3.07 | $250.0K | 1 |
| 2024-12-31 | Buy | Gray Robert | Director | 3,500 | $2.94 | $10.3K | 1 |
| 2024-12-24 | Buy | Shrivastava Sanjay | Director | 5,400 | $2.90 | $15.7K | 1 |
| 2024-12-19 | Buy | BERMAN ROBERT ANDREW | CEO | 12,000 | $2.55 | $30.6K | 1 |
| 2024-12-19 | Buy | Jenusaitis Matthew | Director | 9,620 | $2.53 | $24.3K | 1 |
| 2024-03-13 | Sell | Alavi Hamed | Other C-suite | 8,334 | $6.22 | $51.8K | 1 |
| 2022-08-16 | Buy | Duhay Francis | Director | 7,751 | $6.14 | $47.6K | 1 |
| 2022-06-30 | Buy | Shrivastava Sanjay | Director | 1,000 | $3.85 | $3.8K | 1 |
| 2022-06-27 | Buy | BERMAN ROBERT ANDREW | CEO | 2,500 | $3.80 | $9.5K | 1 |
| 2021-11-19 | Buy | BERMAN ROBERT ANDREW | CEO | 2,000 | $7.43 | $14.9K | 1 |
| 2021-11-16 | Buy | BERMAN ROBERT ANDREW | CEO | 2,000 | $7.87 | $15.7K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Duhay Francis | Director | $297.6K | $9.0K | 2026-09-11 |
| BERMAN ROBERT ANDREW | CEO | $70.7K | $0 | 2024-12-19 |
| Alavi Hamed | Other C-suite | $0 | $51.8K | 2024-03-13 |
| Jenusaitis Matthew | Director | $24.3K | $0 | 2024-12-19 |
| Shrivastava Sanjay | Director | $19.5K | $0 | 2024-12-24 |
| Gray Robert | Director | $10.3K | $0 | 2024-12-31 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2024-12-19 → 2024-12-31 | 5 | $330.9K | 57 | +3.2% (+5.1% raw) | -7.4% (-18.3% raw) | +27.6% (+26.6% raw) | closed |
| 2021-05-17 → 2021-06-16 | 4 | $88.9K | 49 | +16.9% (+22.5% raw) | +38.7% (+40.0% raw) | +25.6% (+31.3% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.